240 related articles for article (PubMed ID: 27412009)
1. Pathogenetics of the RASopathies.
Tidyman WE; Rauen KA
Hum Mol Genet; 2016 Oct; 25(R2):R123-R132. PubMed ID: 27412009
[TBL] [Abstract][Full Text] [Related]
2. The RASopathies.
Rauen KA
Annu Rev Genomics Hum Genet; 2013; 14():355-69. PubMed ID: 23875798
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
Rauen KA; Schoyer L; Schill L; Stronach B; Albeck J; Andresen BS; Cavé H; Ellis M; Fruchtman SM; Gelb BD; Gibson CC; Gripp K; Hefner E; Huang WYC; Itkin M; Kerr B; Linardic CM; McMahon M; Oberlander B; Perlstein E; Ratner N; Rogers L; Schenck A; Shankar S; Shvartsman S; Stevenson DA; Stites EC; Stork PJS; Sun C; Therrien M; Ullian EM; Widemann BC; Yeh E; Zampino G; Zenker M; Timmer W; McCormick F
Am J Med Genet A; 2018 Dec; 176(12):2924-2929. PubMed ID: 30302932
[TBL] [Abstract][Full Text] [Related]
4. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
Tidyman WE; Rauen KA
Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
[TBL] [Abstract][Full Text] [Related]
5. Molecular Genetics of Noonan Syndrome and RASopathies.
Liao J; Mehta L
Pediatr Endocrinol Rev; 2019 May; 16(Suppl 2):435-446. PubMed ID: 31115195
[TBL] [Abstract][Full Text] [Related]
6. RASopathies for Radiologists.
Handa A; Tsujioka Y; Nishimura G; Nozaki T; Kono T; Jinzaki M; Harms T; Connolly SA; Sato TS; Sato Y
Radiographics; 2024 May; 44(5):e230153. PubMed ID: 38602868
[TBL] [Abstract][Full Text] [Related]
7. Expansion of the RASopathies.
Tidyman WE; Rauen KA
Curr Genet Med Rep; 2016 Sep; 4(3):57-64. PubMed ID: 27942422
[TBL] [Abstract][Full Text] [Related]
8. RASopathies: Evolving Concepts in Pathogenetics, Clinical Features, and Management.
Padhiyar J; Mahajan R; Panda M
Indian Dermatol Online J; 2024; 15(3):392-404. PubMed ID: 38845651
[TBL] [Abstract][Full Text] [Related]
9. RASopathies and cardiac manifestations.
Hilal N; Chen Z; Chen MH; Choudhury S
Front Cardiovasc Med; 2023; 10():1176828. PubMed ID: 37529712
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in RASopathies.
Aoki Y; Niihori T; Inoue S; Matsubara Y
J Hum Genet; 2016 Jan; 61(1):33-9. PubMed ID: 26446362
[TBL] [Abstract][Full Text] [Related]
11. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
Rauen KA; Alsaegh A; Ben-Shachar S; Berman Y; Blakeley J; Cordeiro I; Elgersma Y; Evans DG; Fisher MJ; Frayling IM; George J; Huson SM; Kerr B; Khire U; Korf B; Legius E; Messiaen L; van Minkelen R; Nampoothiri S; Ngeow J; Parada LF; Phadke S; Pillai A; Plotkin SR; Puri R; Raji A; Ramesh V; Ratner N; Shankar SP; Sharda S; Tambe A; Vikkula M; Widemann BC; Wolkenstein P; Upadhyaya M
Am J Med Genet A; 2019 Jun; 179(6):1091-1097. PubMed ID: 30908877
[TBL] [Abstract][Full Text] [Related]
12. The RASopathies as an example of RAS/MAPK pathway disturbances - clinical presentation and molecular pathogenesis of selected syndromes.
Bezniakow N; Gos M; Obersztyn E
Dev Period Med; 2014; 18(3):285-96. PubMed ID: 25182392
[TBL] [Abstract][Full Text] [Related]
13. RASopathies - what they reveal about RAS/MAPK signaling in skeletal muscle development.
Rauen KA; Tidyman WE
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38847227
[TBL] [Abstract][Full Text] [Related]
14. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
Rauen KA; Schoyer L; McCormick F; Lin AE; Allanson JE; Stevenson DA; Gripp KW; Neri G; Carey JC; Legius E; Tartaglia M; Schubbert S; Roberts AE; Gelb BD; Shannon K; Gutmann DH; McMahon M; Guerra C; Fagin JA; Yu B; Aoki Y; Neel BG; Balmain A; Drake RR; Nolan GP; Zenker M; Bollag G; Sebolt-Leopold J; Gibbs JB; Silva AJ; Patton EE; Viskochil DH; Kieran MW; Korf BR; Hagerman RJ; Packer RJ; Melese T
Am J Med Genet A; 2010 Jan; 152A(1):4-24. PubMed ID: 20014119
[TBL] [Abstract][Full Text] [Related]
15. Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities.
Gilbert-Dussardier B; Briand-Suleau A; Laurendeau I; Bilan F; Cavé H; Verloes A; Vidaud M; Vidaud D; Pasmant E
Orphanet J Rare Dis; 2016 Jul; 11(1):101. PubMed ID: 27450488
[TBL] [Abstract][Full Text] [Related]
16. RAS diseases in children.
Niemeyer CM
Haematologica; 2014 Nov; 99(11):1653-62. PubMed ID: 25420281
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.
Rauen KA; Huson SM; Burkitt-Wright E; Evans DG; Farschtschi S; Ferner RE; Gutmann DH; Hanemann CO; Kerr B; Legius E; Parada LF; Patton M; Peltonen J; Ratner N; Riccardi VM; van der Vaart T; Vikkula M; Viskochil DH; Zenker M; Upadhyaya M
Am J Med Genet A; 2015 Jan; 167A(1):1-10. PubMed ID: 25393061
[TBL] [Abstract][Full Text] [Related]
18. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
19. Mutational and functional analysis in human Ras/MAP kinase genetic syndromes.
Tidyman WE; Rauen KA
Methods Mol Biol; 2010; 661():433-47. PubMed ID: 20812000
[TBL] [Abstract][Full Text] [Related]
20. [RASopathies and hematologic abnormalities].
Aoki Y
Rinsho Ketsueki; 2015 Oct; 56(10):2240-7. PubMed ID: 26458465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
